Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Halabi, S; Small, EJ; Vogelzang, NJ

Published Date

  • April 1, 2005

Published In

Volume / Issue

  • 23 / 10

Start / End Page

  • 2434 - 2435

PubMed ID

  • 15800342

Pubmed Central ID

  • 15800342

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.05.890

Language

  • eng

Conference Location

  • United States